Wells Fargo Maintains Overweight on Versigent, Raises Price Target to $42
Versigent PLC
Versigent PLC VGNT | 0.00 |
Wells Fargo analyst Colin Langan maintains Versigent (NYSE:
VGNT) with a Overweight and raises the price target from $35 to $42.
Wells Fargo Maintains Overweight on Versigent, Raises Price Target to $42
Versigent PLC VGNT | 0.00 |